March 8, 2023
The Supreme Court's decision as to whether President Joe Biden has the authority to cancel student loan debt will affect the economy and how people think about financing their college education, University of Cincinnati economist Michael Jones said.
March 9, 2023
KYTV News in Springfield, Missouri highlighted the University of Cincinnati's epilepsy transition clinic that helps guide patients as they move from pediatric to adult care.
March 21, 2023
A startup founded by four University of Cincinnati physicians has raised approximately $10 million in funding, including a recent $250,000 investment from St. Elizabeth Healthcare, the Cincinnati Business Courier reported.
March 17, 2023
Aunt Minnie highlighted University of Cincinnati research that found a radiology-oriented transgender curriculum showed success in increasing radiologists' awareness about transgender patients.
March 16, 2023
WLWT highlighted University of Cincinnati's Carla F. Justiniano, MD, in a news story about screening recommendations for colorectal cancer.
March 13, 2023
The University of Cincinnati's Rhonna Shatz, DO, provided expert commentary to Seasons and MSN about a recent study that found taking sleeping pills could raise the risk of Alzheimer's disease.
December 20, 2022
The University of Cincinnati's Alberto Espay joined 55KRC's Simply Medicine program to discuss stiff person syndrome following singer Céline Dion's announcement she has been diagnosed with the neurological condition.
December 19, 2022
National and local media outlets highlighted the partnership between the University of Cincinnati's Dan Arendt and Cincinnati nonprofit Caracole, who have installed a harm reduction vending machine that helps prevent overdoses in Hamilton County.
December 22, 2022
The University of Cincinnati's Christopher Richards, MD, co-authored an accompanying editorial to new research that showed high variability in the way EMS agencies document stroke cases, which was recently featured by MedPage Today.
January 10, 2023
Parkinson's News Today highlighted results of a recent trial, led in the U.S. by the University of Cincinnati's Alberto Espay, that found a liquid drug formulation was more effective than an oral formulation to control symptoms of Parkinson's disease.